Oocyte-based screening system for anti-microtubule agents

Journal of Reproduction and Development

Volumn 50, Issue 6, 2004, Pages 647-652

  Shin, Deug Young ^a,b   Choi, Tae Saeng ^a,b  

^a Dankook University   (South Korea)

^b GenCross Biotech Institute   (South Korea)

Author keywords

Anti microtubule; Oocyte based assay; Taxol; Tubulin; Vinblastine

Indexed keywords

ANTIMICROTUBULE AGENT; ANTINEOPLASTIC AGENT; PACLITAXEL; TUBULIN; UNCLASSIFIED DRUG; VINBLASTINE; METHANOL; MICROTUBULE ASSOCIATED PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SCREENING; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MICROTUBULE; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; OOCYTE; PHENOTYPE; ANIMAL; CHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; METAPHASE; METHODOLOGY; TIME;

ANIMALIA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; METAPHASE; METHANOL; MICE; MICE, INBRED ICR; MICROSCOPY, FLUORESCENCE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; OOCYTES; PACLITAXEL; PHENOTYPE; TIME FACTORS; TUBULIN; VINBLASTINE;

EID: 18244382773     PISSN: 09168818     EISSN: None     Source Type: Journal    
DOI: 10.1262/jrd.50.647     Document Type: Article

References (31)

1. Hamel E. Antimitotic natural products and their interactions with tubulin. Biochemistry 1996; 16: 207-231.
2. Jordan A, Hadfield JA, Lawrence NJ, McGown AT. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 1998; 18: 259-296.
3. Blagosklonny MV, Giannakakou P, El-Deiry WS, Kingston DGI, Higgis PI, Neckers L, Fojo T. Raf-1/ bcl2 phosphorylation: a step from microtubule damage to cell death. Cancer Res 1997; 57: 130-135.
4. Wang LG, Liu XM, Kreis DR, Budman DR. The effect of antimicrotule agents on signal transduction pathways of apoptosis: a review. Cancer Chemother Pharmacol 1999; 44: 355-361.
5. Lehnert M. Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 1996; 32A: 912-920.
6. Germann UA. P-glycoprotein-a mediator of multidrug resistance in tumor cells. Eur J Cancer 1996; 32A: 927-944.
7. Cowden CJ, Paterson I. Cancer drugs better than taxol? Nature 1997; 387: 238-239.
8. Kruczynski A, Hill BT. Vinflunine, the latest vinca alkaloid in clinical development: a review of its preclinical anticancer properties. Crit Rev Oncol Hematol 2001; 40: 159-173.
9. Stachel SJ, Biswas K, Danishefsky SJ. The epothilones, eleutherobins, and related types of molecules. Curr Pharm Des 2001; 7: 1277-1290.
10. Shelanski ML, Gaskin F, Cantor CR. Microtubule assembly in the absence of added nucleotides. Proc Natl Acad Sci USA 1973; 70: 765-768.
11. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667.
12. Schriber SL. Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg Med Chem 1998; 6: 1127-1152.
13. Haggarty SJ, Mayer TU, Miyamoto DT, Fathi R, King RW, Mitchison TJ, Schriber SL. Disscting cellular process using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem & Biol 2000; 7: 275-286.
14. Masui Y. A quest for cytoplasmic factors that control the cell cycle. Prog Cell Cycle Res 1996; 2: 1-13.
15. Choi T, Aoki F, Mori M, Yamashita M, Nagahama Y, Kohmoto K. Activation of p34cdc2 protein kinase activity in meiotic and mitotic cell cycles in mouse oocytes and embryos. Development 1991; 113: 789-795.
16. Maro B, Howlett SK, Webb M. Non-spindle microtubule organizing centers in metaphase II-arrested mouse oocytes. J Cell Biol 1985; 101: 1665-1672.
17. Eichenlaub-Ritter U, Boll I. Nocodazole sensitivity, age-related aneuploidy, and alterations in the cell cycle during maturation of mouse oocytes. Cytogenet. Cell Genet 1989; 52: 170-176.
18. Jagiello G, Ducayen M, Fang JS. Unique effects of spindle inhibitors on mammalian oocyte meiosis. Proc Soc Exp Med 1985; 180: 196-202.
19. Jordan MA, Toso RJ, Thrower D, Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc Natl Acad Sci USA 1993; 90: 9552-9556.
20. Mooberry SL, Tien G, Hernandez AH, Plubrukarn A, Davidson B. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Res 1999; 59: 653-660.
21. Tahir SK, Han E. K-H, Credo B, Jae H-S, Pietenpol JA, Scatena CD, Wu-Wong JR, Frost D, Sham H, Rosenberg SH, Ng Shi-Chung. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors. Cancer Res 2001; 61: 5480-5485.
22. Choi T, Fukasawa K, Zhou R, Tessarollo L, Borror K, Resau J, Vande Woude GF. The mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes. Proc Natl Acad Sci USA 1996; 93: 7032-7035.
23. Witherup KM, Look SA, Stasko MW, Ghiozi TJ, Muschik GM. Taxus spp. Needles contain amounts of Taxol comparable to the bark of Taxus brevifolia: analysis and isolation. J Nat Product 1990; 53(5): 1249-1255.
24. Koulman A, Batterman S, van Putten FM, Bos R, Quax WJ. Lignan profiles of indoor-cultivated anthriscus sylvestris. Planta Med 2003; 69(10): 959-961.
25. Hartwell LH, Culotti J, Reid B. Genetic control of the cell division cycle in yeast I detection mutants. Proc Natl Acad Sci USA 1970; 66: 352-359.
26. Stochwell BR. Frontiers in chemical genetics. Trends Biotechnol. 2000; 18: 449-455.
27. Siracusa G, Whittingham DG, Molinaro M, Vivarelli E. Parthenogenic activation of mouse oocytes induced by inhibitor of protein synthesis. J Embryol Exp Morphol 1978; 43: 157-166.
28. Moses RM, Kline D. Calcium-independent, meiotic spindle-dependent metaphase-to-interphase transition in phorbol ester-treated mouse eggs. Dev Biol 1995; 171: 111-122.
29. Colonna R, Tatone C, Francione A, Rosati F, Callaini G, Corda D, Francesco LD. Protein kinase C is required for the disappearance of MPF upon artificial activation in mouse eggs. Mol Reprod Dev 1997; 48: 292-299.
30. Meijer L, Borgne A, Mulner O, Chong JPJ, Blow JJ, Inagaki N, Inagaki M, Delcros J-G, Moulinoux J-P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 1997; 243: 527-536.
31. Ju J-C, Tsay C, Ruan C-W. Alteration and reversibility in the chromatin, cytoskeleton and development of pig oocytes treated with roscovitine. Mol Repod Dev 2003; 64: 482-491.